HLS Therapeutics (HLS) Competitors

HLS Therapeutics (TSE:HLS) and Tilray Brands (TSE:TLRY) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment.

Is HLS or TLRY more profitable?

Tilray Brands has a net margin of -30.02% compared to HLS Therapeutics' net margin of -38.70%. Tilray Brands' return on equity of -7.24% beat HLS Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HLS Therapeutics	-38.70%	-25.27%	-2.89%
Tilray Brands	-30.02%	-7.24%	-1.41%

Which has preferable earnings & valuation, HLS or TLRY?

HLS Therapeutics has higher earnings, but lower revenue than Tilray Brands. HLS Therapeutics is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HLS Therapeutics	C$40.13M	2.72	-C$15.53M	-C$1.00	-4.91
Tilray Brands	C$610.34M	0.73	-C$183.24M	-C$0.41	-1.67

Do institutionals & insiders believe in HLS or TLRY?

65.2% of HLS Therapeutics shares are owned by institutional investors. Comparatively, 11.2% of Tilray Brands shares are owned by institutional investors. 0.4% of HLS Therapeutics shares are owned by company insiders. Comparatively, 0.7% of Tilray Brands shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Which has more risk & volatility, HLS or TLRY?

HLS Therapeutics has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500. Comparatively, Tilray Brands has a beta of 2.19, suggesting that its share price is 119% more volatile than the S&P 500.

Does the media refer more to HLS or TLRY?

In the previous week, HLS Therapeutics had 1 more articles in the media than Tilray Brands. MarketBeat recorded 1 mentions for HLS Therapeutics and 0 mentions for Tilray Brands. HLS Therapeutics' average media sentiment score of 0.00 equaled Tilray Brands'average media sentiment score.

Company	Overall Sentiment
HLS Therapeutics	Neutral
Tilray Brands	Neutral

Do analysts rate HLS or TLRY?

HLS Therapeutics presently has a consensus price target of C$4.50, indicating a potential downside of 8.16%. Given HLS Therapeutics' stronger consensus rating and higher possible upside, equities analysts plainly believe HLS Therapeutics is more favorable than Tilray Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HLS Therapeutics	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Tilray Brands	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Tilray Brands beats HLS Therapeutics on 8 of the 14 factors compared between the two stocks.